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have greatly enhanced our understanding of tuberculosis transmission
[1, 2]. In settings where molecular tools are regularly employed,
MIRU-VNTR is perhaps the most frequently used. The size of PCR
amplicons spanning either 12, 15, or 24 repeat loci is used to infer a ﬁn-
gerprint for a given isolate, allowing surveillance programs to identify
clusters of isolates potentially related by recent transmission. However,
the increasing use of genomics in national TB surveillance programs is
conﬁrming what many in the TB community have long suspected –
that MIRU-VNTR clusters often do not represent epidemiologically
linked, recently transmitted cases, particularly forMycobacterium tuber-
culosis isolates not belonging to Lineage 4.
In a publication in EBioMedicine, Wyllie et al. benchmark MIRU-
VNTR against genomics using a dataset of over 2000 prospectively col-
lected UK TB isolates, revealing that only 20% of isolates with identical
MIRU-VNTR proﬁles were likely the result of recent transmission
when the genomic data were considered [3]. While single nucleotide
variant (SNV) distances were typically b10 between Lineage 4 isolates
with identical MIRU-VNTR ﬁngerprints, clustered isolates in other line-
ageswere often N100 SNVs apart. An analysis of isolates from recent im-
migrants to the UK versus those who were born in the country or had
been there for more than two years also revealed the extent to which
MIRU-VNTR overestimates clustering – despite identical MIRU-VNTR
proﬁles, isolates in recent immigrants exhibit SNV distances incompat-
ible with recent transmission. Ultimately, Wyllie et al. conﬁrm that
MIRU-VNTR overestimates TB transmission in certain settings, particu-
larly amongst individuals from countries where lineages other than Lin-
eage 4 dominate [3]. While some of these insights are not new [4] – it is
common practice to run a more variable set of MIRU loci for Lineage 2
strains to better capture relatedness – the scale of these analyses reveals
just how much more powerful genomics is at identifying potential
recent transmission and raises important questions about the future of
MIRU-VNTR in well-resourced settings.DOI of original article: https://doi.org/10.1016/j.ebiom.2018.07.019.
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real-time investigation is unclear. Fingerprinting requires DNA from
culture-positive isolates with results often taking upwards of a month
to arrive, and there is limited evidence to suggest that MIRU-VNTR
directly impacts case-ﬁnding and outbreak management in a meaning-
ful way. While we have previously shown that TB program staff report
high conﬁdence in interpreting MIRU-VNTR data [6], anecdotal evi-
dence suggests that someof the intricacies of interpretation, particularly
around identical patterns in recent immigrants, are not always clear to
all parties involved in an investigation. Together with Wyllie et al.'s
data demonstrating the clear superiority of genomics at revealing true
recent transmission, these observations suggest that settings currently
relying on MIRU-VNTR for insights into local epidemiology would be
better served by implementing a real-time genomics platform instead.
Whereas MIRU-VNTR is restricted to identifying clusters, relying on
contact investigation to draw inferences around transmission, geno-
mics' resolution can be leveraged to identify directional transmission
events, greatly facilitating investigations in challenging situations,
where populationsmight be hard to reach,where contacts go unnamed,
or where survey instruments might fail to yield actionable information.
Thus, the limited resources available to local TB prevention programs
can be more strategically deployed to mitigate ongoing transmission.
Implementing routine genomics is not simple however [7]. Beyond
the oft-cited economical and operational obstacles, there are substantial
interpretive challenges. It is common practice to use SNV thresholds to
deﬁne linkage by recent transmission [8], such as the ﬁve SNV threshold
used byWyllie et al. Such thresholds are sensitive to the bioinformatics
pipeline used to analyze the data [8], and they assume a constant, low
substitution rate. If the organism has accumulated an unusual number
of SNVs – there is evidence that substitution ratesmay vary in active dis-
ease as a result of host factors, such as co-morbidities, and possibly also
in latent infection – a case may not be linked to its transmission cluster.
Furthermore, inferring the underlying phylogeny and associated trans-
mission networks requires additional analyses. Recent approaches to
this problem take advantage of state-of-the-art phylogenetic modelling
and integration of relevant biological and epidemiological parameters,
such as the pathogen's substitution rate or infectious period of the
host [9]; however, our knowledge about the ranges of those parameters
is still limited.While an operational deﬁnition of transmission based onC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
5I. Comas, J.L. Gardy / EBioMedicine 34 (2018) 4–5SNV threshold is a useful placeholder for public health agencies engaged
in routine genomic surveillance, further work is needed to address gaps
in our understanding of the genomic, clinical, and epidemiological
aspects of TB transmission if we are to truly leverage genomics as a
tool to advance TB elimination efforts.
Ultimately, Wyllie et al. bring us one step closer to closing the gaps
between contact investigation, genotyping, and genomic epidemiology,
presenting evidence to help TB molecular surveillance programs to
choose the best tool for their needs. This is particularly relevant in the
era of TB elimination in low-burden countries, where TB is not seen as
a priority area for public health funding. With the promising reports of
genomics as replacement for phenotypic drug sensitivity testing [10]
and the possibility of interrogating the pathogen genome directly
from sputum samples [7], we envision a future in which TB genomic
epidemiology will be integral to local and global tuberculosis surveil-
lance and prevention programs.
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